Biomimetic Red Blood Cell Membrane-Mediated Nanodrugs Loading Ursolic Acid for Targeting NSCLC Therapy

SIMPLE SUMMARY: Lung cancer is the second most common cancer after breast cancer. Non-small-cell lung cancer, which represents more than 85% of all lung cancer subtypes, is known for its tumor progression and metastasis, resulting in poor clinical outcomes. Conventional therapies for NSCLC, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ting, Yan, Dan, Hou, Wenjun, Jiang, Hui, Wu, Min, Wang, Yanling, Chen, Gang, Tang, Chunming, Wang, Yijun, Xu, Huae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496832/
https://www.ncbi.nlm.nih.gov/pubmed/36139680
http://dx.doi.org/10.3390/cancers14184520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496832/
https://www.ncbi.nlm.nih.gov/pubmed/36139680
http://dx.doi.org/10.3390/cancers14184520

Ejemplares similares